Plasma homocysteine levels and mortality in patients with coronary artery disease
- PMID: 9227928
- DOI: 10.1056/NEJM199707243370403
Plasma homocysteine levels and mortality in patients with coronary artery disease
Abstract
Background: Elevated plasma homocysteine levels are a risk factor for coronary heart disease, but the prognostic value of homocysteine levels in patients with established coronary artery disease has not been defined.
Methods: We prospectively investigated the relation between plasma total homocysteine levels and mortality among 587 patients with angiographically confirmed coronary artery disease. At the time of angiography in 1991 or 1992, risk factors for coronary disease, including homocysteine levels, were evaluated. The majority of the patients subsequently underwent coronary-artery bypass grafting (318 patients) or percutaneous transluminal coronary angioplasty (120 patients); the remaining 149 were treated medically.
Results: After a median follow-up of 4.6 years, 64 patients (10.9 percent) had died. We found a strong, graded relation between plasma homocysteine levels and overall mortality. After four years, 3.8 percent of patients with homocysteine levels below 9 micromol per liter had died, as compared with 24.7 percent of those with homocysteine levels of 15 micromol per liter or higher. Homocysteine levels were only weakly related to the extent of coronary artery disease but were strongly related to the history with respect to myocardial infarction, the left ventricular ejection fraction, and the serum creatinine level. The relation of homocysteine levels to mortality remained strong after adjustment for these and other potential confounders. In an analysis in which the patients with homocysteine levels below 9 micromol per liter were used as the reference group, the mortality ratios were 1.9 for patients with homocysteine levels of 9.0 to 14.9 micromol per liter, 2.8 for those with levels of 15.0 to 19.9 micromol per liter, and 4.5 for those with levels of 20.0 micromol per liter or higher (P for trend=0.02). When death due to cardiovascular disease (which occurred in 50 patients) was used as the end point in the analysis, the relation between homocysteine levels and mortality was slightly strengthened.
Conclusions: Plasma total homocysteine levels are a strong predictor of mortality in patients with angiographically confirmed coronary artery disease.
Comment in
-
Plasma homocysteine levels and mortality in patients with coronary artery disease.N Engl J Med. 1997 Nov 27;337(22):1631-2; author reply 1632-3. doi: 10.1056/NEJM199711273372215. N Engl J Med. 1997. PMID: 9411226 No abstract available.
-
Plasma homocysteine levels and mortality in patients with coronary artery disease.N Engl J Med. 1997 Nov 27;337(22):1632; author reply 1632-3. N Engl J Med. 1997. PMID: 9411227 No abstract available.
-
Plasma homocysteine levels and mortality in patients with coronary artery disease.N Engl J Med. 1997 Nov 27;337(22):1632-3. N Engl J Med. 1997. PMID: 9411228 No abstract available.
Similar articles
-
N-terminal pro-B-type natriuretic peptide and long-term mortality in stable coronary heart disease.N Engl J Med. 2005 Feb 17;352(7):666-75. doi: 10.1056/NEJMoa042330. N Engl J Med. 2005. PMID: 15716560
-
Markers of myocardial damage and inflammation in relation to long-term mortality in unstable coronary artery disease. FRISC Study Group. Fragmin during Instability in Coronary Artery Disease.N Engl J Med. 2000 Oct 19;343(16):1139-47. doi: 10.1056/NEJM200010193431602. N Engl J Med. 2000. PMID: 11036119 Clinical Trial.
-
A prospective cohort study of predictive value of homocysteine in patients with type 2 diabetes and coronary artery disease.Clin Chim Acta. 2006 Nov;373(1-2):70-6. doi: 10.1016/j.cca.2006.05.011. Epub 2006 May 16. Clin Chim Acta. 2006. PMID: 16814762
-
Prognostic value of free plasma homocysteine levels in patients hospitalized with acute coronary syndrome.Am J Cardiol. 2008 Jul 15;102(2):135-9. doi: 10.1016/j.amjcard.2008.03.022. Epub 2008 May 28. Am J Cardiol. 2008. PMID: 18602509
-
[Fibrinogen and coronary heart disease].Versicherungsmedizin. 1995 Aug 1;47(4):122-6. Versicherungsmedizin. 1995. PMID: 7676548 Review. German.
Cited by 190 articles
-
The association between homocysteine and ischemic stroke subtypes in Chinese: A meta-analysis.Medicine (Baltimore). 2020 Mar;99(12):e19467. doi: 10.1097/MD.0000000000019467. Medicine (Baltimore). 2020. PMID: 32195946 Free PMC article.
-
Imbalance of Homocysteine and H2S: Significance, Mechanisms, and Therapeutic Promise in Vascular Injury.Oxid Med Cell Longev. 2019 Nov 22;2019:7629673. doi: 10.1155/2019/7629673. eCollection 2019. Oxid Med Cell Longev. 2019. PMID: 31885816 Free PMC article. Review.
-
Does Information on Blood Heavy Metals Improve Cardiovascular Mortality Prediction?J Am Heart Assoc. 2019 Nov 5;8(21):e013571. doi: 10.1161/JAHA.119.013571. Epub 2019 Oct 19. J Am Heart Assoc. 2019. PMID: 31631727 Free PMC article.
-
Cardiovascular disease in transgendered people: A review of the literature and discussion of risk.JRSM Cardiovasc Dis. 2019 Sep 30;8:2048004019880745. doi: 10.1177/2048004019880745. eCollection 2019 Jan-Dec. JRSM Cardiovasc Dis. 2019. PMID: 31620275 Free PMC article. Review.
-
Metabolomics reveals a link between homocysteine and lipid metabolism and leukocyte telomere length: the ENGAGE consortium.Sci Rep. 2019 Aug 12;9(1):11623. doi: 10.1038/s41598-019-47282-6. Sci Rep. 2019. PMID: 31406173 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
-
Full Text Sources
-
Other Literature Sources
-
Medical
-
Miscellaneous